Introduction
Genomic and post-genomic studies have accelerated the comprehensive understanding of molecular mechanisms underlying physiological and pathological phenomena. Moreover, such integrated information is radically transforming the drug discovery process. In this context, the identification of whole cellular protein networks has become the most important goal. Thus, many types of analytical systems for proteomic research have been reported, including 2-D electrophoresis, 1,2 2-D HPLC, 3, 4 the Mass-tag system, [5] [6] [7] and the protein microarray. [8] [9] [10] These tools will offer a range of new information on protein interactions and protein expression levels.
On the other hand, post-translational modification is also important for a full understanding of life. Especially, protein phosphorylation is a core event of intracellular signal transduction, which is directly connected to cellular function. [11] [12] [13] Thus, a dynamic and comprehensive analysis of cellular phosphorylation would provide a new framework for the understanding of life and, of course, for the drug discovery. Intracellular substrates of protein kinases are proteins. Thus, a protein microarray should be appropriate for this purpose, but the proteins are generally difficult to handle due to their poor stability and the laborious preparations that they require. On the other hand, peptides are chemically stable and easy to design, prepare, and handle. In many cases, the biological activities of proteins can be substituted by shorter peptides that are taken from the primary sequences.
Actually, several peptide microarrays have been reported for the detection of protein kinase activity on solid supports, [14] [15] [16] [17] [18] and some of them are already commercially available. However, such peptide arrays have not yet been adapted to detect actual intracellular protein kinase activities using cell lysate, but have just been applied to screen substrates or inhibitors of certain kinases, so that isolated kinase enzymes are needed. If such peptide microarrays are applied to detect protein kinase activities in cell lysate, the high level of nonspecific adsorption of various materials in cell lysate disturbs an accurate evaluation. However, the monitoring of intracellular protein kinase activity is important for diagnosis, because hyper-or hypo-activation of certain protein kinase activities is related to many diseases. Thus, a peptide array system, which can be applied to the assay using cell lysate, will be a useful tool of diagnosis. Moreover, such an array will also be useful for drug screening, because the target protein kinase can be assayed without any isolation or purification of the enzyme.
We attempted here to detect protein kinase activity in cell lysate using our original peptide microarray with fluorescence imaging.
This method used a very simple peptide immobilization and detecting technique, and could sensitively detect protein kinase activities. In addition, this array could also detect protein kinase activation or inactivation in response to drug stimulation using cell lysate. This is the first peptide array that can detect the intracellular fluctuation of protein kinase activity with drug stimulation.
Experimental

Reagents and chemicals
A microwell glass slide coated with amino groups was purchased from Matsunami Glass Ind., Ltd. (Osaka, Japan). Rink amide resin and Fmoc-amino acids were purchased from Novabiochem. 2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU), N-hydroxybenzotriazole (HOBt), piperidine, and N-methylpyrrolidone (NMP) were purchased from Watanabe Chemical Industries, Ltd. (Hiroshima, Japan). DMF for peptide synthesis grade and acetonitrile for HPLC grade were obtained from Kanto Chemical Co., Ltd. (Tokyo, Japan). Trifluoroacetic acid (TFA), 1,2-ethandithiol, and glutaraldehyde were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).
Triisopropylsilane was purchased from Tokyo Kasei Kogyo Co., Ltd. (Tokyo, Japan). A catalytic subunit of cyclic AMP-dependent protein kinase (PKA) was purchased from Promega Corporation (Madison, WI, USA). Protein kinase C, alpha isozyme (PKCα), was from Sigma Chemical (St. Louis, MO, USA). Phos-tag ® biotin was from Toyobo (Osaka, Japan). Streptavidin, DyLight TM 647 conjugated was from Pierce Biotechnology, Inc. (Rockford, IL, USA). Cy TM 3 labelled streptavidin was purchased from Amersham Biosciences (Chalfont St. Giles, Bucks, UK). Forskolin and H-89 were purchased from Wako Pure Chemical Industries and Biomolecular Research Laboratories Inc. (Plymouth Meeting, PA, USA), respectively. An insulintransferrin-selenium-A supplement was purchased from Invitrogen (Carlsbad, CA, USA).
Peptide synthesis
Peptides were synthesized with an APEX 396 Multiple Peptide Synthesizer (Advanced ChemTech, Louisville, KY, USA) at a 10 μmol scale on Fmoc chemistry using corresponding Fmoc-amino acids. The resin was Rink Amide AM resin for C-terminal amide in peptides. Peptides were cleaved from the resin using a cleavage solution containing 94% TFA, 2.5% water, 2.5% 1,2-ethandithiol, and 1% triisopropylsilane. The resin was then filtered out and the filtrate was added to cold diethylether for precipitation of the cleaved peptide. The obtained peptide was purified by HPLC equipped with an electrospray mass spectrometer for the detector (Micromass Platform II connected with a Waters Alliance HPLC system using a SunFire TM C18 column). The purified peptides were then lyophilized.
Cell culture and preparation of cell lysate
MCF-7 cells (Health Science Research Resources Bank, Japan) were cultured in Minimum Essential Medium (MEM) supplemented with 10% fetal bovine serum (FBS), 1% antibiotic-antimycotic, 1% MEM non-essential amino acids, and a 1% insulin-transferrin-selenium-A in a humidified atmosphere containing 5% CO2, 95% air at 37˚C. The cultured cells were stimulated with 10 μM of forskolin (Fsk) for 30 min. In the case of stimulation of the PKA inhibitor, the cultured cells were preincubated with 30 μM H-89 for 1 h, and then exposed to a fresh medium containing 10 μM Fsk for 30 min. After stimulation, the cells were washed twice with Dulbecco's phosphate buffered saline (-) (D-PBS) and isolated using a cell scraper. The isolated cells were centrifuged at 800 rpm for 5 min at 4˚C. After the supernatant was removed, the cells were resuspended in D-PBS and sonicated 3 times for 10 s on ice to homogenize. The homogenate was then centrifuged at 100000g for 1 h at 4˚C, and the supernatant was used as cell lysate. Protein concentrations were determined using the Bradford reagent (BioRad Laboratories, Hercules, CA, USA).
Preparation of a peptide array
An amine-coated glass slide was reacted with 1% glutaraldehyde in NaHCO3 (pH 9.5) for 2 h at 37˚C. After incubation, the slide was washed twice with water for 3 min with sonication. One millimolar of a cysteine-terminated substrate peptide solution (NaHCO3, pH 9.5) containing 1 mM of tris(carboxyethyl)phosphine was spotted on an aldehyde- modified slide, and then allowed to stand for immobilization overnight. The slide was washed 3 times with 25 mM Trisbuffered saline containing 0.05% Tween 20 (TBS-T) for 3 min with sonication.
On-chip phosphorylation and detection
In the phosphorylation reaction for PKA, the peptide array was reacted with a PKA assay buffer (10 mM HEPES, 10 mM MgCl2, 0.2 mM ATP, pH 7) containing 200 units/ml of PKA or 100 μg/ml MCF-7 cell lysate for 1 h at 37˚C. In the phosphorylation reaction for PKC, the peptide array was reacted with a PKC assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 0.1 mM ATP, 0.5 mM CaCl2, 2 μg/ml diacylglycerol, 2.5 μg/ml phosphatidylserine, pH 7.5) containing 1 μg/ml of PKCα for 1 h at 37˚C. After the phosphorylation reaction, the slide was washed 3 times with TBS containing 1% SDS and one time water for 5 min with sonication, respectively, and then incubated for 30 min at room temperature in a 10 mM HEPES buffer, pH 7.3, including 10 μg/ml biotinylated Phos-tag, 200 mM NaNO3, 1 mM Zn(NO3)2, 0.005% Tween20 and 10% ethanol. The slide was then washed for 2 min in water under sonication. After a treatment with biotinylated Phos-tag, the slide was incubated for 10 min at room temperature with 10 mM HEPES buffer (pH 7.3) including 2 μg/ml DyLight 647 or Cy3-labeled streptavidin. The slide was then washed with TBS-T and water, and subsequently analyzed using the Packard BioScience Scan Array Lite (Packard Bioscience, Boston, MA, USA). Fluorescence intensities were calculated as the mean of those from 4 independent spots.
Results and Discussion
Strategy for phosphorylation detection
The strategy for phosphorylation of the fabricated peptide arrays is illustrated in Fig. 1 . Glutaraldehyde was reacted with amino groups on a glass slide to create an aldehyde surface. Next, N-terminal-cysteine in each peptide was attached to the aldehyde surface by forming a thiazolidine ring. 19 This immobilization method was reported as being regioselective (terminal cysteine-specific), and is also favorable for the uniform orientation of immobilized peptides. A peptideimmobilized glass slide was incubated with kinase (isolated enzyme or cell lysate) and ATP. After the phosphorylation reaction, the slide was incubated with a biotinylated zinc complex (Phos-tag) and a fluorescence-labeled streptavidin. Detection of on-chip phosphorylation was performed by fluorescence imaging using a microarray scanner.
Detection of phosphoamino acid-containing peptides with the Phos-tag
We first investigated whether or not the Phos-tag molecule actually recognizes a phosphoamino acid containing peptides immobilized on a glass slide. Phos-tag is a zinc(II) chelate compound, which binds to the phosphate group. 20 In this study, this compound was applied to the detection of phosphorylated peptide on a glass slide. To examine whether or not the Phostag recognizes the phosphate group regardless of the phosphoamino acid types, we synthesized peptides containing phosphoserine, threonine, or tyrosine (as positive controls), respectively (Table 1) . Together with such pre-phosphorylated positive control peptides, substrate peptides, which should be phosphorylated by a target kinase, and negative control peptides, in which serine/threonine or tyrosine residue was changed to alanine or phenylalanine, respectively, were immobilized on aldehyde-coated glass slides. Figure 2 shows that Phos-tag recognized only the phosphorylated forms independent of their amino acid sequences and phosphorylated amino acids, but did not recognize any types of the unphosphorylated form. Also, there was no nonspecific adsorption of the probe or other components in the spotting area. These results indicated that the Phos-tag probe was appropriate for a protein kinase assay using this peptide array system. 273 ANALYTICAL SCIENCES MARCH 2007, VOL. 23 Table 1 Amino acid sequences of the peptides used
The target phosphorylation site residues are underlined. All peptides were engineered with CXX, where X indicates Gly or 8-amino-3,6-dioxaoctanoic acid at the N-terminus for immobilization on glass slides. 
Detection of PKA and PKC activity
PKA and PKC are well-studied representatives of serine/threonine protein kinases. We selected PKA and PKC as target kinases and measured these protein kinase activities using the peptide microarray. The substrate peptide for PKA or PKC was immobilized, and an on-chip phosphorylation reaction was performed. As a control, a phosphorylation reaction was performed in the absence of enzyme or ATP. In the presence of PKA, the fluorescence intensity from the substrate peptide, PKA (S), was equal to that from its positive control peptide, PKA (Sp) (Fig. 3A) . In addition, the fluorescence intensity of PKA (S) was equal to that of the negative control peptide, PKA (A), in the absence of PKA. This result showed that PKA (S) could be completely phosphorylated by PKA on a solid support. In the case of PKC, the obtained result was similar to that of PKA. However, the fluorescence intensity from PKC (S) obtained in the presence of ATP was smaller than that from its positive control peptide, PKC (Sp). This means that on-chip phosphorylation with PKC was slower than that with PKA in this array. A determination of the time course in on-chip phosphorylation with PKA or PKC also supported this consideration (data not shown). However, the PKC (S) phosphorylation efficiency was still quite high for practical use (Fig. 3B) . These results suggested that our peptide microarray is applicable to the detection of protein kinase activity.
Detection of PKA activation or inactivation in drug-stimulated cell lysate
To confirm that our peptide microarray can detect intracellular kinase activity, we attempted to detect PKA activity using drugstimulated MCF-7 cell lysate. MCF-7 cells were incubated with forskolin or H-89. Then, each drug-stimulated cell lysate was prepared for an attempt to detect the intracellular PKA activity together with that in unstimulated cell lysate using our peptide array. Since Fsk is an agonist of adenylate cyclase, it activates PKA in MCF-7 cells. 21 H-89 is a selective PKA inhibitor, and inhibits Fsk-induced PKA activation. 22 The fluorescence intensity of PKA (S), obtained by unstimulated cell lysate (Fsk (-)), was higher than that of PKA (A) (Fig. 4A) . Moreover, the fluorescence intensity of PKA (S) obtained by Fsk-stimulated cell lysate (Fsk (+)) was about twice that of PKA (S) by Fsk (-), demonstrating the successful detection of intracellular PKA activation by Fsk. In contrast, the fluorescence intensity of PKA (S), obtained by Fsk and H-89-stimulated cell lysate (Fsk (+), H-89 (+)), was very similar to that of PKA (S) obtained by the unstimulated cell lysate (control), suggesting the inhibiting action of H-89 against the Fsk-induced PKA activation. These results indicated that our peptide microarray detected intracellular protein kinase activity.
Conclusions
Our peptide array successfully monitored intracellular PKA activity. This is the first example of the monitoring of drugstimulated perturbation of intracellular enzymes using a peptide chip. This array system should be able to monitor many kinds of protein kinase activities at the same time, and thus should be a useful technical base for drug discovery. 
